[go: up one dir, main page]

CO4900050A1 - Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba - Google Patents

Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba

Info

Publication number
CO4900050A1
CO4900050A1 CO97040267A CO97040267A CO4900050A1 CO 4900050 A1 CO4900050 A1 CO 4900050A1 CO 97040267 A CO97040267 A CO 97040267A CO 97040267 A CO97040267 A CO 97040267A CO 4900050 A1 CO4900050 A1 CO 4900050A1
Authority
CO
Colombia
Prior art keywords
alkyl
low
hydrogen
weight alkyl
weight
Prior art date
Application number
CO97040267A
Other languages
English (en)
Inventor
Pamela Albaugh
Alan Hutchison
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1997/004623 external-priority patent/WO1997034870A1/en
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of CO4900050A1 publication Critical patent/CO4900050A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Multicomponent Fibers (AREA)

Abstract

Un compuesto de la fórmula: o sus sales no tóxicas farmacéuticamente aceptables en donde: T es halógeno, hidrógeno, hidroxi, nitro, amino o alcoxi de bajo peso; X es hidrógeno, hidroxilo o alquilo de bajo peso; W es fenilo o fenilaquilo en donde cada alquilo está opcionalmente sustituido con hasta 5 grupos independientemente seleccionados a partir de halógeno, hidroxi,alquilo de bajo peso, cicloalquilo que tiene de 3-7 átomos de carbono, amino, mono o dialquilamino en donde cada alquilo es independientemente alquilo de bajo peso o cicloalquilo que tiene de 3-7 átomos de carbono, alcoxi de bajo peso, cicloalquil alcoxi que tiene de 3-7 átomos de carbono, alquilendioxi, o NR1 COR2 , COR2 , o CONR1 R2 en donde R1 y R2 son iguales o diferentes y representan hidrógeno, alquilo de bajo peso o cicloalquilo que tiene de 3-7 átomos de carbono; y representa en donde: - 2 -Y representa nitrógeno o C-R4 ; representa N-R7 o un átomo de carbono sustituido con R8 y R9 , n es 1, 2, 3 ó 4; R3 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilaquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; R4 es halógeno o trifluormetilo; o -OR10 , -COR10 , -CO2 R10 , -OCOR10 , o -R10 en donde R10 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilaquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o -CONR11 R12 o (CH2 )m NR11 R12 , en donde m es 0, 1, ó 2; R11 representa hidrógeno, alquilo de bajo peso, y R12 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o NR11 R12 forma un grupo heterocíclico el cual es morfolinilo, piperidinilo, pirrolidinilo, o N-alquil piperazinilo; R5 y R6 son iguales o diferentes y representan hidrógeno, halógeno, alquilo de bajo peso, o alcoxi de bajo peso; R7 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; R8 es hidrógeno o alquilo de bajo peso; y R9 es COR13 , CO2 R13 o -R13 , en donde R13 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o R9 es CONR14 R15 o -(CH2 )k NR14 R15 , en donde k es 0, 1, ó 2; R14 representa hidrógeno, alquilo de bajo peso, y R15 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o NR14 R15 forma un grupo heterocíclico el cual es morfolilo, piperidilo, pirrolidilo, o N-alquil piperazilo.
CO97040267A 1996-07-16 1997-07-16 Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba CO4900050A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/683,066 US5750702A (en) 1993-10-27 1996-07-16 Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
PCT/US1997/004623 WO1997034870A1 (en) 1996-03-22 1997-03-20 Certain fused pyrrolecarboxamides as gaba brain receptor ligands

Publications (1)

Publication Number Publication Date
CO4900050A1 true CO4900050A1 (es) 2000-03-27

Family

ID=24742434

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97040267A CO4900050A1 (es) 1996-07-16 1997-07-16 Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba

Country Status (10)

Country Link
US (2) US5750702A (es)
AU (2) AU2832897A (es)
CO (1) CO4900050A1 (es)
DZ (1) DZ2271A1 (es)
HR (1) HRP970385A2 (es)
MA (1) MA27120A1 (es)
PA (1) PA8434101A1 (es)
PE (1) PE91798A1 (es)
WO (2) WO1998002433A1 (es)
ZA (1) ZA976244B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034870A1 (en) 1996-03-22 1997-09-25 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
CZ20001769A3 (cs) 1997-11-13 2001-09-12 Pfizer Products Inc. Způsob výroby pyrrolkarboxamidů
PT1048651E (pt) * 1997-12-03 2003-09-30 Taisho Pharmaceutical Co Ltd Compostos tetraciclicos contendo azoto
EP1056724B1 (en) 1998-02-26 2005-05-25 Neurogen Corporation Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
AU2879799A (en) * 1998-02-26 1999-09-15 Neurogen Corporation 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands
JPH11279040A (ja) 1998-03-27 1999-10-12 Kao Corp 皮膚外用剤
GB9812038D0 (en) 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
EP1177177B1 (en) * 1999-05-06 2005-02-23 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
US6375948B1 (en) 1999-07-12 2002-04-23 Kao Corporation Treating method for suppressing hair growth
US20050014939A1 (en) * 1999-08-31 2005-01-20 Neurogen Corporation Fused pyrrolecarboxamides: GABA brain receptor ligands
US7109351B1 (en) * 1999-08-31 2006-09-19 Neurogen Corporation Fused pyrrolecarboxamides; GABA brain receptor ligands
AU2001264932A1 (en) 2000-05-26 2001-12-11 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
AU2001277731A1 (en) * 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
WO2002046155A1 (en) * 2000-12-04 2002-06-13 Pfizer Products Inc. Synthesis of fused pyrrolecarboxamides
US6861529B2 (en) * 2001-07-06 2005-03-01 Pfizer Inc Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
US20060100196A1 (en) * 2001-09-24 2006-05-11 Andrea Gailunas Substituted amines for the treatment of alzheimer's disease
BR0214301A (pt) * 2001-11-19 2004-10-13 Neurogen Corp Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratar doenças ou condições, para potencializar um efeito terapêutico de um agente do snc, para melhorar a memória recente de um paciente, para determinar a presença ou ausência de um receptor de gabaa em uma amostra, e para alterar a atividade de transdução de sinal de receptor de gabaa, preparação farmacêutica acondicionada, e, uso de um composto ou sal
US6673811B1 (en) * 2001-11-19 2004-01-06 Neurogen Corporation 1H-pyrrolo [3,2-b] pyridine-3-carboxylic acid amines as GABAA receptor ligands
EP1472252A1 (en) * 2002-02-07 2004-11-03 Neurogen Corporation Substituted fused pyrazolecarboxylic acid arylamides and related compounds
US20040122218A1 (en) * 2002-12-20 2004-06-24 Sean Turner Pyrrolopyridine potassium channel openers
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
JP2009513672A (ja) * 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド 神経発生のgaba受容体媒介調節
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
AU2007312936B2 (en) 2006-10-16 2013-09-26 Bionomics Limited Novel anxiolytic compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2012222874B2 (en) 2011-03-02 2015-04-16 Bionomics Limited Novel small-molecules as therapeutics
WO2012151640A1 (en) 2011-05-12 2012-11-15 Bionomics Limited Methods for preparing naphthyridines
US12157753B2 (en) * 2019-01-17 2024-12-03 ViiV Healthcare UK (No.4) Limited Process for preparing Fostemsavir

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) * 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU652968B2 (en) * 1990-10-09 1994-09-15 Neurogen Corporation Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
AU2832897A (en) 1998-02-09
HRP970385A2 (en) 1998-08-31
WO1998002420A1 (en) 1998-01-22
PA8434101A1 (es) 2000-05-24
US5925770A (en) 1999-07-20
ZA976244B (en) 1999-01-21
US5750702A (en) 1998-05-12
PE91798A1 (es) 1999-01-07
AU3660497A (en) 1998-02-09
WO1998002433A1 (en) 1998-01-22
DZ2271A1 (fr) 2002-12-18
MA27120A1 (fr) 2005-01-03

Similar Documents

Publication Publication Date Title
CO4900050A1 (es) Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba
FI961776A0 (fi) Tiettyjä fuusioituneita pyrrolikarboksianilideja; uusi aivojen GABA-reseptoriligandien luokka
CO5630036A2 (es) Nuevos derivados indol con afinidad por el receptor 5-ht6
CY1110399T1 (el) Ρυθμιστες της τετραϋδροπυρανυλο κυκλοπεντυλο τετραϋδροπυριδοπυριδινης για την ενεργοτητα των υποδοχεων των χημειοκινων
FI911096A0 (fi) N-(4-piperidyl) dihydrobenzofuran)karboxamid- eller n-(4-piperidyl)(dihydro-2h- benzopyran) karboxamidderivat.
ES2193839B1 (es) Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
CY1108352T1 (el) Υποκατασταθεισες 1,4-βενζοδιαζεπινες και χρησεις τους για την αγωγη του καρκινου
CO4650042A1 (es) Derivados de 6-fenilpiridil-2-amina
CO5601018A2 (es) Derivados de n-fenil-2-pirimidin-amina
AR035548A1 (es) Compuestos organicos
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
CY1106858T1 (el) Νεα παραγωγα κυκλικου αμιδιου
ATE383338T1 (de) N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
TW200510309A (en) Chemical compounds
DK0888356T3 (da) Kondenserede 2,3-benzodiazepinderivater og deres anvendelse som AMPA-receptohaemmere
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
DE60000978D1 (de) 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases
CO4900049A1 (es) Ciertas pirrolacarboxamidas fusionadas; una nueva clase de ligandos receptores cerebrales de gaba
DK1716097T3 (da) Ny fremgangsmåde til syntese af en-amidderivater